Sale!
report_pricing

Free Sample Report

£59.00 Free!

One Report – Weeks 09-12 2016

Acitretin, Alvimopan, Amprenavir, Apixaban, Bosutinib, Canagliflozin, Capecitabine, Darunavir, Eltrombopag, Emtricitabine, Enzalutamide, Eribulin, Eribulin, Flucytosine, Fosamprenavir, Lacosamide, Lacosamide, Lenvatinib, Nintedanib, Olodaterol, Palbociclib, Rivaroxaban, Ruxolitinib, Silodosin, Sofosbuvir, Tafamidis, Tedizolid, Tedizolid, Ticagrelor, Ticagrelor

SKU: tcipatent-fr-0912-2016 Tag:
What is a Claimed Intermediate?
A Claimed Intermediate is here defined as a novel pharmaceutical process intermediate which is preferably highly stable, highly isolatable, highly purifiable (optionally with appropriate chirality) and claimed as a compound in a pharmaceutical process patent specification from which it may be subject to a 20 year patent protection term.